PartsTable
Technical Data Sheet
Download PDF

1592912 — MILRINONE LACTATE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

1592912: MILRINONE LACTATE INJECTION.

The MILRINONE LACTATE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, secondary_container_type: PACKAGE, total_primary_container_quantity: 10, primary_container_content_quantity: 1.0 MILLILITERS, part_name_assigned_by_controlling_agency: MILRINONE LACTATE IN DEXTROSE INJECTION, 100ML, 10S. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-694-5728, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
1592912
NSN: 6505-01-694-5728
FSC: 6505 — Drugs and Biologicals
CAGE: 89875 — DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA (USA)
SPECIFICATIONS
administrationINTRAVENOUS
secondary_container_typePACKAGE
total_primary_container_quantity10
primary_container_content_quantity1.0 MILLILITERS
part_name_assigned_by_controlling_agencyMILRINONE LACTATE IN DEXTROSE INJECTION, 100ML, 10S
NSN6505-01-694-5728
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available MILRINONE LACTATE INJECTION TITLE COMPONENT PN 1592912 MFR MILRINONE LACTATE INJE
KEY FEATURES
•
ADMINISTRATION: INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 1.0 MILLILITERS
•
SECONDARY CONTAINER TYPE: PACKAGE
•
TOTAL PRIMARY CONTAINER QUANTITY: 10
TECHNICAL CHARACTERISTICS
ADMINISTRATIONINTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY1.0 MILLILITERS
SECONDARY CONTAINER TYPEPACKAGE
SPECIAL FEATURESINDICATED FOR THE SHORT-TERM INTRAVENOUS TREATMENT OF PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE; CONTRAINDICATED IN PATIENTS WHO ARE HYPERSENSITIVE TO IT; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); AVOID FREEZING; EXPOSURE OF PHARMACEUTICAL PRODUCTS TO HEAT SHOULD BE MINIMIZED; AVOID EXCESSIVE HEAT; NO PRESERVATIVE IS ADDED; SUPPLIED AS 100 ML (200 MCG/ML) IN 5% DEXTROSE INJECTION SINGLE UNITS; PACKAGE OF 10.
PART NAME ASSIGNED BY CONTROLLING AGENCYMILRINONE LACTATE IN DEXTROSE INJECTION, 100ML, 10S
TOTAL PRIMARY CONTAINER QUANTITY10
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 2
6505NCM217014Reference document
Same NSN cross-reference
Reference document — Secondary reference
NDC00409-2776-23Same NSN cross-reference
Same NSN cross-reference
Also cataloged under this NSN
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy 1592912?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 1592912?
1592912 is a MILRINONE LACTATE INJECTION.
What parts can replace 1592912?
There are 2 known substitutes for 1592912: 6505NCM217014, NDC00409-2776-23. Substitute compatibility should be verified for your specific system.
What is the NSN for 1592912?
1592912 is cataloged in the U.S. Government catalog under NSN 6505-01-694-5728. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — 1592912